Accessibility Menu
C4x Discovery Plc logo

C4x Discovery Plc(LSE) C4XD

This security has been delisted. This page is retained for historical reference.

C4x Discovery Plc last closing stock price
MetricPriceDate
Last closeGBX 12.002024-04-25
C4x Discovery Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+40.35%GBX 8.552024-04-18
1 month-9.09%GBX 13.202024-03-26
3 month-9.09%GBX 13.202024-01-26
Year to date+33.33%GBX 9.002023-12-29
1 year-99.18%GBX 1,465.002023-04-26
3 year-99.72%GBX 4,330.002021-04-26
5 year-99.8%GBX 5,929.412019-04-26
Since inception-88.26%GBX 1.022014-10-23

C4XD News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

C4XD Financials

Key Financial Metrics (TTM)

Gross Margin

97.78%

Operating Margin

-784.44%

Net Income Margin

-649.77%

Return on Equity

-121.19%

Return on Capital

-192.84%

Return on Assets

-126.49%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

£28.24M

Operating Income

-£758.00K

EBITDA

£36.00K

Operating Cash Flow

-£3.40M

Capital Expenditure

-£55.00K

Free Cash Flow

-£3.45M

Cash & ST Invst.

£13.13M

Total Debt

£258.00K

C4x Discovery Plc Performance Analysis

C4x Discovery Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-07-31GBP 5,642,000N/A
20222022-07-31GBP 2,699,000-52.2%
20232023-07-31GBP 1,710,000-36.6%
C4x Discovery Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42022-07-313889.4%
Q22023-01-31-36.3%
Q42023-07-31-98.0%
Q22024-01-3172388.2%
C4x Discovery Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-07-31GBP -0.02N/A
20222022-07-31GBP -0.0482.1%
20232023-07-31GBP -0.0423.8%
C4x Discovery Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42022-07-3119.7%
Q22023-01-312.5%
Q42023-07-31-85.2%
Q22024-01-31346.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2024YOY CHG

Revenue

£24.65M

+37242.4%

Gross Profit

£24.47M

+20658.8%

Gross Margin

99.27%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

49

N/A

Net Income

£17.80M

+494.0%

EBITDA

£17.99M

+432.8%

Quarterly Fundamentals

Name
Q2 2024YOY CHG

Total Cash

£13.13M

+12.4%

Total Debt

£258.00K

-13.1%

Accounts Receivable

£11.58M

+217.8%

Inventory

£0.00

+100.0%

Long Term Debt

£0.00

-100.0%

Short Term Debt

£253.00K

+48.0%

Return on Assets

-1.26%

N/A

Return on Invested Capital

-2.03%

N/A

Free Cash Flow

£9.08M

+261.5%

Operating Cash Flow

£9.09M

+262.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MTPH.LMidatech Pharma plc
£0.18+1794.74%
OKYO.LOKYO Pharma Limited
£0.01-24.32%
SNG.LSynairgen plc
£0.01+0.00%
NSCI.LNetScientific plc
£0.53-0.71%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$92.32-0.08%
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.